nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

08.09.2018 | Original Article

Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study

verfasst von: Igor Diemberger, Rachele Bonfiglioli, Cristian Martignani, Maddalena Graziosi, Mauro Biffi, Stefano Lorenzetti, Matteo Ziacchi, Cristina Nanni, Stefano Fanti, Giuseppe Boriani

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

¹⁸F-FDG PET/CT is an emerging technique for diagnosis of cardiac implantable electronic devices infection (CIEDI). Despite the improvements in transvenous lead extraction (TLE), long-term survival in patients with CIEDI is poor. The aim of the present study was to evaluate whether the extension of CIEDI at ¹⁸F-FDG PET/CT can improve prediction of survival after TLE.

Methods

Prospective, monocentric observational study enrolling consecutive candidates to TLE for a diagnosis of CIEDI. ¹⁸F-FDG PET/CT was performed in all patients prior TLE.

Results

There were 105 consecutive patients with confirmed CIEDI enrolled. An increased ¹⁸F-FDG uptake was limited to cardiac implantable electrical device (CIED) pocket in 56 patients, 40 patients had a systemic involvement. We had nine negative PET in patients undergoing prolonged antimicrobial therapy (22.5 ± 14.0 days vs. 8.6 ± 13.0 days; p = 0.005). Implementation of ¹⁸F-FDG PET/CT in modified Duke Criteria lead to reclassification of 23.8% of the patients. After a mean follow-up of 25.0 ± 9.0 months, 31 patients died (29.5%). Patients with CIED pocket involvement at ¹⁸F-FDG PET/CT presented a better survival independently of presence/absence of systemic involvement (HR 0.493, 95%CI 0.240–0.984; p = 0.048). After integration of ¹⁸F-FDG PET/CT data, absence of overt/hidden pocket involvement in CIEDI and a (glomerular filtration rate) GFR < 60 ml/min were the only independent predictors of mortality at long term.

Conclusions

Patient with CIEDI and a Cold Closed Pocket (i.e., a CIED pocket without skin erosion/perforation nor increased capitation at ¹⁸F-FDG PET/CT) present worse long-term survival. Patient management can benefit by systematic adoption of pre-TLE ¹⁸F-FDG PET/CT through improved identification of CIED related endocarditis (CIEDIE) and hidden involvement of CIED pocket.

Diemberger I, Mazzotti A, Giulia MB, Cristian M, Matteo M, Letizia ZM, et al. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices. 2013;10(4):551–73. https://doi.org/10.1586/17434440.2013.811837.CrossRefPubMed

Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16(10):1490–5. https://doi.org/10.1093/europace/euu147.CrossRefPubMed

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128. https://doi.org/10.1093/eurheartj/ehv319.CrossRefPubMed

Maytin M, Jones SO, Epstein LM. Long-term mortality after transvenous lead extraction. Circ Arrhythm Electrophysiol. 2012;5(2):252–7. https://doi.org/10.1161/CIRCEP.111.965277.CrossRefPubMed

Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54(9):1333–41. https://doi.org/10.1093/cid/cis193.CrossRefPubMed

Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Quintana E, et al. Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: a cross-sectional study. J Nucl Med. 2016;57(11):1726–32. https://doi.org/10.2967/jnumed.116.173690.CrossRefPubMed

Graziosi M, Nanni C, Lorenzini M, Diemberger I, Bonfiglioli R, Pasquale F, et al. Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging. 2014;41(8):1617–23. https://doi.org/10.1007/s00259-014-2773-z.CrossRefPubMed

Bongiorni MG, Burri H, Deharo JC, Stark C, Kennergren C, Saghy L, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018. https://doi.org/10.1093/europace/euy050.CrossRef

Bonfiglioli R, Nanni C, Morigi JJ, Graziosi M, Trapani F, Bartoletti M, et al. (1)(8)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging. 2013;40(8):1190–6. https://doi.org/10.1007/s00259-013-2426-7.CrossRefPubMed

10.

Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, et al. Predictors of long-term survival free from relapses after extraction of infected CIED. Europace. 2017. https://doi.org/10.1093/europace/eux121.CrossRef

11.

Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8. https://doi.org/10.1086/313753.CrossRefPubMed

12.

Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98(9):724–31. https://doi.org/10.1136/heartjnl-2012-301627.CrossRefPubMed

13.

Diemberger I, Migliore F, Biffi M, Cipriani A, Bertaglia E, Lorenzetti S, et al. The "subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: an observational prospective multicenter study. Int J Cardiol. 2018;250:146–9. https://doi.org/10.1016/j.ijcard.2017.07.061.CrossRefPubMed

14.

Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (multicenter electrophysiologic device infection cohort). J Am Coll Cardiol. 2012;59(7):681–7. https://doi.org/10.1016/j.jacc.2011.11.011.CrossRefPubMed

15.

De Maria E, Diemberger I, Vassallo PL, Pastore M, Giannotti F, Ronconi C, et al. Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent. J Cardiovasc Med (Hagerstown). 2014;15(7):554–64. https://doi.org/10.2459/JCM.0000000000000008.CrossRef

16.

Shariff N, Eby E, Adelstein E, Jain S, Shalaby A, Saba S, et al. Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. J Cardiovasc Electrophysiol. 2015;26(7):783–9. https://doi.org/10.1111/jce.12684.CrossRefPubMed

17.

Lewis GF, Gold MR. Safety and efficacy of the subcutaneous implantable defibrillator. J Am Coll Cardiol. 2016;67(4):445–54. https://doi.org/10.1016/j.jacc.2015.11.026.CrossRefPubMed

18.

Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A leadless Intracardiac transcatheter pacing system. N Engl J Med. 2016;374(6):533–41. https://doi.org/10.1056/NEJMoa1511643.CrossRefPubMed

19.

Tarakji KG, Mittal S, Kennergren C, Corey R, Poole J, Stromberg K, et al. Worldwide randomized antibiotic EnveloPe infection PrevenTion trial (WRAP-IT). Am Heart J. 2016;180:12–21. https://doi.org/10.1016/j.ahj.2016.06.010.CrossRefPubMed

20.

Ahmed FZ, James J, Cunnington C, Motwani M, Fullwood C, Hooper J, et al. Early diagnosis of cardiac implantable electronic device generator pocket infection using (1)(8)F-FDG-PET/CT. Eur Heart J Cardiovasc Imaging. 2015;16(5):521–30. https://doi.org/10.1093/ehjci/jeu295.CrossRefPubMedPubMedCentral

21.

Amraoui S, Tlili G, Sohal M, Berte B, Hindie E, Ritter P, et al. Contribution of PET imaging to the diagnosis of septic embolism in patients with pacing lead endocarditis. JACC Cardiovasc Imaging. 2016;9(3):283–90. https://doi.org/10.1016/j.jcmg.2015.09.014.CrossRefPubMed

22.

Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, et al. Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085–104. https://doi.org/10.1016/j.hrthm.2009.05.020.CrossRefPubMed

23.

Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59(18):1616–25. https://doi.org/10.1016/j.jacc.2011.11.059.CrossRefPubMed

24.

Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10(4). https://doi.org/10.1161/CIRCIMAGING.116.005772.

25.

Gomes A, Glaudemans A, Touw DJ, van Melle JP, Willems TP, Maass AH, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis. 2017;17(1):e1–e14. https://doi.org/10.1016/S1473-3099(16)30141-4.CrossRefPubMed

Titel: Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study
verfasst von: Igor Diemberger
Rachele Bonfiglioli
Cristian Martignani
Maddalena Graziosi
Mauro Biffi
Stefano Lorenzetti
Matteo Ziacchi
Cristina Nanni
Stefano Fanti
Giuseppe Boriani
Publikationsdatum: 08.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4142-9

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study

Abstract

Purpose

Methods

Results

Conclusions

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial

William T. O’Brien Sr. Top 3 Differentials in Radiology. A Case Review

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging

68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation

18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study